Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Queen's University
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed Patient Information and Consent.
Patients with primary Post-Traumatic Stress Disorder (as diagnosed by MINI) and DSM IV TR.
Patients with CAPS score of at least 40.
Males or females between 18-65 years of age.
Patients not taking PTSD pharmacotherapy for at least last 2 weeks prior to commencing in the study or if they are taking PTSD pharmacotherapy it must be stable for at least 6 weeks prior to the start and not be changed during the 6 weeks of the study treatment phase.
Individual or group supportive psychotherapy may continue during the study but will not be allowed to start new psychotherapy during the 6 weeks of the study treatment phase.
You may not be if
Current primary Axis I disorder including Schizophrenia, Bipolar Disorder type I, Major Depressive Disorder.
Other primary Axis I disorders which, in the opinion of the investigator, may affect the outcome of this study.
Patients with HDRS score ≥ 18.
A metallic implant in cranium (except the mouth).
Patients with severe or unstable medical conditions, which in the opinion of the investigator would interfere with their progress or safety.
ECT treatment within the last three months.
Patients with a history of epilepsy.
Patients with neurological disorder leading to increased intracranial pressure.
Patients with severe cardiac disorder or intracardiac lines and pacemakers.
Patients with current suicide risk ≥ 6 points by MINI.
